Evidence map›Paper›PMID 32437472›Full record

ArticlePloS one2020

Effects of PUMILIO1 and PUMILIO2 knockdown on cardiomyogenic differentiation of human embryonic stem cells culture.

Isabelle Leticia Zaboroski Silva, Anny Waloski Robert, Guillermo Cabrera Cabo, Lucia Spangenberg, Marco Augusto Stimamiglio, Bruno Dallagiovanna, Daniela Fiori Gradia, Patrícia Shigunov

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Isabelle Leticia Zaboroski SilvaLaboratory of Basic Biology of Stem Cells (LABCET), Instituto Carlos Chagas-FIOCRUZ-PR, Curitiba, Paraná, Brazil.
Anny Waloski RobertLaboratory of Basic Biology of Stem Cells (LABCET), Instituto Carlos Chagas-FIOCRUZ-PR, Curitiba, Paraná, Brazil.
Guillermo Cabrera CaboBioinformatics Unit, Instituto Pasteur de Montevideo, Montevideo, Uruguay.
Lucia SpangenbergBioinformatics Unit, Instituto Pasteur de Montevideo, Montevideo, Uruguay.
Marco Augusto StimamiglioLaboratory of Basic Biology of Stem Cells (LABCET), Instituto Carlos Chagas-FIOCRUZ-PR, Curitiba, Paraná, Brazil.
Bruno DallagiovannaLaboratory of Basic Biology of Stem Cells (LABCET), Instituto Carlos Chagas-FIOCRUZ-PR, Curitiba, Paraná, Brazil.
Daniela Fiori GradiaDepartment of Genetics, Federal University of Parana (UFPR), Curitiba, Paraná, Brazil.
Patrícia ShigunovLaboratory of Basic Biology of Stem Cells (LABCET), Instituto Carlos Chagas-FIOCRUZ-PR, Curitiba, Paraná, Brazil.ORCID 0000-0001-6443-1529
Fundação Carlos Chagas · BRInstitut Pasteur de Montevideo · UYUniversidade Federal do Paraná · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Posttranscriptional regulation plays a fundamental role in the biology of embryonic stem cells (ESCs). Many studies have demonstrated that multiple mRNAs are coregulated by one or more RNA-binding proteins (RBPs) that orchestrate mRNA expression. A family of RBPs, which is known as the Pumilio-FBF (PUF) family, is highly conserved among different species and has been associated with the undifferentiated and differentiated states of different cell lines. In humans, two homologs of the PUF family have been found: Pumilio 1 (PUM1) and Pumilio 2 (PUM2). To understand the role of these proteins in human ESCs (hESCs), we first assessed the influence of the silencing of PUM1 and PUM2 on pluripotency genes and found that the knockdown of Pumilio genes significantly decreased the OCT4 and NANOG mRNA levels and reduced the amount of nuclear OCT4, which suggests that Pumilio proteins play a role in the maintenance of pluripotency in hESCs. Furthermore, we observed that PUM1-and-PUM2-silenced hESCs exhibited improved efficiency of in vitro cardiomyogenic differentiation. Through an in silico analysis, we identified mRNA targets of PUM1 and PUM2 that are expressed at the early stages of cardiomyogenesis, and further investigation will determine whether these target mRNAs are active and involved in the progression of cardiomyogenesis. Our findings contribute to the understanding of the role of Pumilio proteins in hESC maintenance and differentiation.

Indexed as

Cell DifferentiationGene Expression Regulation, DevelopmentalHuman Embryonic Stem CellsHumansNanog Homeobox ProteinOctamer Transcription Factor-3RNA-Binding ProteinsRNA, MessengerNanog Homeobox ProteinNANOG protein, humanOctamer Transcription Factor-3POU5F1 protein, humanPUM1 protein, humanPUM2 protein, humanRNA-Binding ProteinsRNA, Messenger

Identifiers

PMID32437472
PMCPMC7241771
OpenAlexW3026585895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.